ISRGIntuitive Surgical

$452.30+4.1% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though revenue growing +20% year on year.

1 good, 2 neutral
Revenue trend+20% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +16% a year.

Earnings trend+9% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−0.7 points operating

Trailing-twelve-month operating margin, 28.5% now against 29.2% a year earlier.

All from SEC EDGAR, as of Sep 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 87% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ISRG growing?

Intuitive Surgical's revenue has grown 19% a year over three years, and grown 16% a year over five, with earnings per share compounding at 25%.

+19%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+16%

Revenue growth, 5-year rate · +19% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+25%

Earnings per share, 3-year rate · revenue +19% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$5.71B
Revenue FY2022
$6.22B
Revenue FY2023
$7.12B
Revenue FY2024
$8.35B
Revenue FY2025
$10.1B

Annual income statements as filed with the SEC.

On our screens:R&D leaders